Sionna Therapeutics Inc (SION)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 11,292 | 13,147 | 0 |
| Operating Income | -11,292 | -13,147 | N/A |
| Other Income | 2,740 | 1,300 | 0 |
| Pre-tax Income | -8,552 | -11,847 | 0 |
| Net Income Continuous | -8,552 | -11,847 | N/A |
| Net Income | $-8,552 | $-11,847 | $N/A |
| EPS Basic Total Ops | -2.71 | -3.84 | N/A |
| EPS Basic Continuous Ops | -2.71 | -3.84 | N/A |
| EPS Diluted Total Ops | -2.71 | -3.84 | N/A |
| EPS Diluted Continuous Ops | -2.71 | -3.84 | N/A |
| EBITDA(a) | $-12,229 | $-13,092 | $N/A |